Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

Immatics Biotechnologies GmbH Active

Scientific & Education


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of Immatics Biotechnologies GmbH

According to Immatics Biotechnologies GmbH latest financial report submitted on 2023-12-31, the company has a Turnover of €54M, Cash of €218M while the Total-Assets is €510M. Compared with the previous year, the company reported a Turnover increase of 48.15%, which is an equivalent of 80.0 million. At the same time, the Cash went up by 96.0%, or by 428.2 million.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Turnover

For more information you can

Upgrade plan
  • Reporting period

    12

  • Consolidated A/cs

    Y

  • Profit after Tax

    € -94.6 million

  • Working Capital

    € 292.8 million

Working Capital

Business Credit Report

A Credit Report Immatics Biotechnologies GmbH is available for instant download. When we generate this report, we took into account that the company is 25 year old, Turnover €54M, Cash €218M and the Total-Assets of €510M. Next, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, is considered a high level of corporate failures.


Overall Credit Risk for

Immatics Biotechnologies GmbH

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

Employees

Immatics Biotechnologies GmbH currently employees 26 people. The management level consists of 8.33% of manager level, 0.00% of senior level, 25.00% of cxo level, 62.50% of director level, 4.17% of vp level, 0.00% of partner level, 0.00% of non-manager level.


Total Employee Count

Total employees

26

Management Level


25

Top

63

Middle

8

Operational

Employee Job Title Email Phone Country
Harpreet Singh CXO
**************@immatics.com
- DE
Mark Bleckmann Officer
-
- DE
Thomas Peter Ulmer Managing Director
-
- DE
Niels Philipp Nikolaus Emmerich Managing Director
-
- DE
Paul G. Higham Managing Director
-
- DE

Get direct emails & phone numbers for senior executives working at «Immatics Biotechnologies GmbH»

Build your list of contacts and filter them by job title seniority level, age nationality and export the list to XL, Salesforce or via API

Download Extension

Group Structure

Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Now

Immatics Biotechnologies GmbH Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at Immatics Biotechnologies GmbH. One of of major shareholders of Immatics Biotechnologies GmbH is 683 Capital Management LLC, which owns 1350000 ORDINARY shares, with a total value of 14,850,000 USD and Price (T.Rowe) U.S. Small-Cap Value Equity Trust, which owns 185609 ORDINARY shares, with a total value of 2,041,699 USD and T. Rowe Price Investment Management, Inc., which owns 2213115 ORDINARY shares, with a total value of 24,344,265 USD and Price (T.Rowe) Small Cap Stock Fund, which owns 740723 ORDINARY shares, with a total value of 8,147,953 USD and Lord Abbett Securities Trust-Micro-Cap Growth Fund, which owns 200550 ORDINARY shares, with a total value of 2,206,050 USD.


Name Quantity Share Type Value
683 Capital Management LLC
1350000 ORDINARY 14850000 USD
Price (T.Rowe) U.S. Small-Cap Value Equity Trust
185609 ORDINARY 2041699 USD
T. Rowe Price Investment Management, Inc.
2213115 ORDINARY 24344265 USD
Price (T.Rowe) Small Cap Stock Fund
740723 ORDINARY 8147953 USD
Lord Abbett Securities Trust-Micro-Cap Growth Fund
200550 ORDINARY 2206050 USD

See All Beneficial Owners & Shareholders

Unlock Full Access

Competitors:

Top 5 similar companies of Immatics Biotechnologies GmbH are Formycon AG, Merz Pharma GmbH & Co. KGaA, BRAIN Biotech AG, Ferring GmbH, Gematria Test Lab GmbH. View and export all the competitor list of Immatics Biotechnologies GmbH by upgrading your account here.


Formycon AG


Revenue
77,696,000.0
Age
18 years
Employees
250
Industry
View Scientific & Education
Website
View http://form*********

Merz Pharma GmbH & Co. KGaA


Revenue
370,405,748.47
Age
23 years
Employees
3396
Industry
View Financial Services
Website
View https://m********

BRAIN Biotech AG


Revenue
55,335,000.0
Age
25 years
Employees
296
Industry
View Business & Professional Associations
Website
View https://www.bra**************

Ferring GmbH


Revenue
505,434,826.7
Age
21 years
Employees
389
Industry
View Scientific & Education
Website
View http://fer********

Gematria Test Lab GmbH


Revenue
2,936,542.46
Age
20 years
Employees
286
Industry
View Scientific & Education
Website
View http://gematria*************

View & Export Competitors:

Get the complete list with detailed profiles

Start Now

Immatics Biotechnologies GmbH news & activities:


Turnover

Immatics Biotechnologies GmbH has submitted new account statements and has reported a turnover of €54M, a 48.15% decrease year-over-year.

de.globaldatabase.com

2023-12-31

EBITDA

The Immatics Biotechnologies GmbH-based company said the adjusted EBITDA is now -€89M, compared with the previous year of -88929000.

de.globaldatabase.com

2023-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start Now

Frequently Asked Questions regarding Immatics Biotechnologies GmbH


Where is Immatics Biotechnologies GmbH registered office?

Immatics Biotechnologies GmbH is located at Paul-ehrlich-strasse 15, Germany.

How can I contact Immatics Biotechnologies GmbH?

You can call Immatics Biotechnologies GmbH at the following number +497071*****

What is the website of Immatics Biotechnologies GmbH?

Immatics Biotechnologies GmbH website is https://immatics.com/

How many people work at Immatics Biotechnologies GmbH?

According to the latest account statement, there are currently 26 of employees working for Immatics Biotechnologies GmbH.

How much revenue does Immatics Biotechnologies GmbH make?

Based on the latest financial accounts submitted on 2023-12-31, the company made €54M for 2023, which went up by 48.15%.

What is Immatics Biotechnologies GmbH EBITDA?

For 2023, Immatics Biotechnologies GmbH has reported an EBITDA of -€89M, which went down by 0.0% compared to previous year.

What is the Business Credit Score of Immatics Biotechnologies GmbH and how reliable is the company?

In order to check the business credit score of Immatics Biotechnologies GmbH, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does Immatics Biotechnologies GmbH pay their invoices on time?

By requesting a Business Credit Report for Immatics Biotechnologies GmbH, you will be able to gain more insights about the Immatics Biotechnologies GmbH payment trends.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Explore API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action